AbbVie
Revision as of 14:11, 10 April 2015 by Josh Leeson (talk | contribs)
AbbVie is a research-based biopharmaceutical company.
AbbVie began as the pharmaceutical leader, Abbott, which was founded in 1888 by Chicago physician, Dr. Wallace Abbott. In 2011 the companines split into Abbott and AbbVie. On January 1, 2013, AbbVie was founded as a global biopharmaceutical company with 'focus and capabilities to address some of the world’s greatest health challenges'. [1]
Contents
Staff
Board of Directors
- Richard A. Gonzalez
- Robert J. Alpern
- Roxanne S. Austin
- William H.L. Burnside
- Edward M. Liddy
- Edward J. Rapp
- Roy S. Roberts
- Glenn F. Tilton
- Frederick H. Waddell
AbbVie Leadership
- RIchard A. Gonzalez - Chairman of the Board and chief executive officer
- Laura J. Schumacher - Executive vice president, business development, external affairs and general counsel
- William J. Chase - Executive vice president, chief financial officer
- Carlos Alban - Executive vice president, commercial operations
- Michael E. Severino - Executive vice president, research & development and chief scientific officer
- Timothy J. Richmond - Senior vice president, human resources
- Azita Saleki- Gerhardt - Senior vice president, operations
- Karen Hale - Vice president, chief ethics and compliance officer [2]
- Tony Sampson - Director of government affairs
Affiliations
AbbVie is a donor to the Science Media Centre. [3]
Lobbying firms
Contact
Web site: www.abbvie.co.uk Address: AbbVie Ltd, Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4XE, UK
Notes
- ↑ About us Abbvie company website, accessed 5 November 2014
- ↑ Abbvie Leadership abbvie, accessed 8 April 2015
- ↑ SMC, Funding, accessed 29 September 2013. See also Science Media Centre - Funding
- ↑ Register 1st September 2014 - 30th November 2014 APPC, accessed 28 January 2015
- ↑ Register 1st September 2014 - 30th November 2014 APPC, accessed 29 January 2015
